Compare $GRDX vs $MGX | Chartloom

Compare

$GRDX vs $MGX

GridAI Technologies Corp · Metagenomi Therapeutics Inc

GRDX

GridAI Technologies Corp

MGX

Metagenomi Therapeutics Inc

Compare $GRDX vs $MGX

Comparing GridAI Technologies Corp and Metagenomi Therapeutics Inc

GRDXGridAI Technologies Corp

MGXMetagenomi Therapeutics Inc

GRDXGridAI Technologies Corp

Market cap

$34M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.3%

52W performance

24.2%

FCF yield

-24.2%

MGXMetagenomi Therapeutics Inc

Market cap

$38M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.83x

Rev growth (TTM)

-50.7%

YTD performance

-40.1%

52W performance

-68.7%

FCF yield

-227.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GRDX

MGX

Detailed metrics comparison

GRDX

GridAI Technologies Corp

MGX

Metagenomi Therapeutics Inc

Market Cap

GRDX$34M

MGX$38M

Enterprise Value

GRDX$34M

MGX$-1M

Price

GRDX$4.97

MGX$1.00

P/E Ratio

GRDXN/A

MGXN/A

P/S Ratio

GRDX209.46x

MGX2.72x

EV/Sales

GRDX211.31x

MGX-0.10x

EV/EBITDA

GRDX0.00x

MGX0.00x

P/B Ratio

GRDX1.94x

MGX0.34x

P/FCF Ratio

GRDXN/A

MGXN/A

EV/FCF

GRDX-4.17x

MGX0.02x

PEG Ratio

GRDXN/A

MGXN/A

Forward P/E (NTM)

GRDXN/A

MGXN/A

Forward P/S (NTM)

GRDXN/A

MGX3.83x

Revenue (TTM)

GRDX$160K

MGX$14M

Revenue Growth (YoY)

GRDXN/A

MGX-50.7%

Forward Rev Growth

GRDX0.0%

MGX30.0%

Gross Margin (TTM)

GRDX-815.2%

MGX0.0%

Operating Margin (TTM)

GRDX0.0%

MGX0.0%

EBITDA Margin (TTM)

GRDX-6577.4%

MGX-491.3%

Net Margin (TTM)

GRDX-12994.7%

MGX-477.5%

FCF Margin (TTM)

GRDX-5062.9%

MGX-620.9%

Net Income (TTM)

GRDX$-21M

MGX$-66M

FCF (TTM)

GRDX$-8M

MGX$-86M

EPS (TTM)

GRDX-$3.25

MGX$0.00

ROE (TTM)

GRDX-5679.0%

MGX-5123.0%

ROA (TTM)

GRDX-3050.0%

MGX-3662.0%

ROIC (TTM)

GRDX-5425.0%

MGX-5123.0%

Cash

GRDX$1M

MGX$39M

Debt

GRDX$2M

MGX$0

Net Cash/Debt

GRDX$-297K

MGX$39M

Current Ratio (TTM)

GRDX0.16x

MGX4.50x

Quick Ratio (TTM)

GRDX0.13x

MGX4.37x

Debt/Equity (TTM)

GRDX0.12x

MGX0.00x

Debt/Assets (TTM)

GRDX0.0%

MGX0.0%

Interest Coverage (TTM)

GRDXN/A

MGXN/A

Net Debt/EBITDA (TTM)

GRDX0.00x

MGX0.00x

Beta

GRDX1.72

MGX0.68

52W Performance

GRDX24.2%

MGX-68.7%

YTD Performance

GRDX-3.3%

MGX-40.1%

% from 52W High

GRDX-28.3%

MGX-74.7%

% from 52W Low

GRDX165.8%

MGX4.2%

Asset Turnover (TTM)

GRDX0.00x

MGX0.10x

FCF Yield (TTM)

GRDX-24.2%

MGX-227.9%

Earnings Yield (TTM)

GRDX-62.0%

MGX-175.2%

Dividend Yield (TTM)

GRDXN/A

MGXN/A

Rule of 40

GRDX-5,062.9

MGX-671.6

EV/GP/RG

GRDXN/A

MGXN/A

Ticker research

View GRDX research View MGX research

Metric	GRDX GridAI Technologies Corp	MGX Metagenomi Therapeutics Inc
Market & Valuation
Market Cap	$34M	$38M
Enterprise Value	$34M	$-1M
Price	$4.97	$1.00
P/E Ratio	N/A	N/A
P/S Ratio	209.46x	2.72x
EV/Sales	211.31x	-0.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.94x	0.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.17x	0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.83x
Revenue & Growth
Revenue (TTM)	$160K	$14M
Revenue Growth (YoY)	N/A	-50.7%
Forward Rev Growth	0.0%	30.0%
Profitability
Gross Margin (TTM)	-815.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6577.4%	-491.3%
Net Margin (TTM)	-12994.7%	-477.5%
FCF Margin (TTM)	-5062.9%	-620.9%
Net Income (TTM)	$-21M	$-66M
FCF (TTM)	$-8M	$-86M
EPS (TTM)	-$3.25	$0.00
ROE (TTM)	-5679.0%	-5123.0%
ROA (TTM)	-3050.0%	-3662.0%
ROIC (TTM)	-5425.0%	-5123.0%
Financial Health
Cash	$1M	$39M
Debt	$2M	$0
Net Cash/Debt	$-297K	$39M
Current Ratio (TTM)	0.16x	4.50x
Quick Ratio (TTM)	0.13x	4.37x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.72	0.68
52W Performance	24.2%	-68.7%
YTD Performance	-3.3%	-40.1%
% from 52W High	-28.3%	-74.7%
% from 52W Low	165.8%	4.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.10x
FCF Yield (TTM)	-24.2%	-227.9%
Earnings Yield (TTM)	-62.0%	-175.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5,062.9	-671.6
EV/GP/RG	N/A	N/A
Ticker research	View GRDX research	View MGX research

Valuation

P/S Ratio

MGX

2.72x

GRDX

209.46x

EV/FCF

GRDX

-4.17x

MGX

0.02x

Growth & revenue

Revenue Growth TTM

MGX

-50.7%

Forward Revenue Growth

MGX

30.0%

GRDX

0.0%

Profitability & performance

Gross Margin

MGX

0.0%

GRDX

-815.2%

ROE

MGX

-5123.0%

GRDX

-5679.0%

FCF Yield %

GRDX

-24.2%

MGX

-227.9%

52-Week Performance

GRDX

24.2%

MGX

-68.7%

Detailed metrics comparison

GRDX

GridAI Technologies Corp

MGX

Metagenomi Therapeutics Inc

Market Cap

GRDX$34M

MGX$38M

Enterprise Value

GRDX$34M

MGX$-1M

Price

GRDX$4.97

MGX$1.00

P/E Ratio

GRDXN/A

MGXN/A

P/S Ratio

GRDX209.46x

MGX2.72x

EV/Sales

GRDX211.31x

MGX-0.10x

EV/EBITDA

GRDX0.00x

MGX0.00x

P/B Ratio

GRDX1.94x

MGX0.34x

P/FCF Ratio

GRDXN/A

MGXN/A

EV/FCF

GRDX-4.17x

MGX0.02x

PEG Ratio

GRDXN/A

MGXN/A

Forward P/E (NTM)

GRDXN/A

MGXN/A

Forward P/S (NTM)

GRDXN/A

MGX3.83x

Revenue (TTM)

GRDX$160K

MGX$14M

Revenue Growth (YoY)

GRDXN/A

MGX-50.7%

Forward Rev Growth

GRDX0.0%

MGX30.0%

Gross Margin (TTM)

GRDX-815.2%

MGX0.0%

Operating Margin (TTM)

GRDX0.0%

MGX0.0%

EBITDA Margin (TTM)

GRDX-6577.4%

MGX-491.3%

Net Margin (TTM)

GRDX-12994.7%

MGX-477.5%

FCF Margin (TTM)

GRDX-5062.9%

MGX-620.9%

Net Income (TTM)

GRDX$-21M

MGX$-66M

FCF (TTM)

GRDX$-8M

MGX$-86M

EPS (TTM)

GRDX-$3.25

MGX$0.00

ROE (TTM)

GRDX-5679.0%

MGX-5123.0%

ROA (TTM)

GRDX-3050.0%

MGX-3662.0%

ROIC (TTM)

GRDX-5425.0%

MGX-5123.0%

Cash

GRDX$1M

MGX$39M

Debt

GRDX$2M

MGX$0

Net Cash/Debt

GRDX$-297K

MGX$39M

Current Ratio (TTM)

GRDX0.16x

MGX4.50x

Quick Ratio (TTM)

GRDX0.13x

MGX4.37x

Debt/Equity (TTM)

GRDX0.12x

MGX0.00x

Debt/Assets (TTM)

GRDX0.0%

MGX0.0%

Interest Coverage (TTM)

GRDXN/A

MGXN/A

Net Debt/EBITDA (TTM)

GRDX0.00x

MGX0.00x

Beta

GRDX1.72

MGX0.68

52W Performance

GRDX24.2%

MGX-68.7%

YTD Performance

GRDX-3.3%

MGX-40.1%

% from 52W High

GRDX-28.3%

MGX-74.7%

% from 52W Low

GRDX165.8%

MGX4.2%

Asset Turnover (TTM)

GRDX0.00x

MGX0.10x

FCF Yield (TTM)

GRDX-24.2%

MGX-227.9%

Earnings Yield (TTM)

GRDX-62.0%

MGX-175.2%

Dividend Yield (TTM)

GRDXN/A

MGXN/A

Rule of 40

GRDX-5,062.9

MGX-671.6

EV/GP/RG

GRDXN/A

MGXN/A

Ticker research

View GRDX research View MGX research

Metric	GRDX GridAI Technologies Corp	MGX Metagenomi Therapeutics Inc
Market & Valuation
Market Cap	$34M	$38M
Enterprise Value	$34M	$-1M
Price	$4.97	$1.00
P/E Ratio	N/A	N/A
P/S Ratio	209.46x	2.72x
EV/Sales	211.31x	-0.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.94x	0.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.17x	0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.83x
Revenue & Growth
Revenue (TTM)	$160K	$14M
Revenue Growth (YoY)	N/A	-50.7%
Forward Rev Growth	0.0%	30.0%
Profitability
Gross Margin (TTM)	-815.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6577.4%	-491.3%
Net Margin (TTM)	-12994.7%	-477.5%
FCF Margin (TTM)	-5062.9%	-620.9%
Net Income (TTM)	$-21M	$-66M
FCF (TTM)	$-8M	$-86M
EPS (TTM)	-$3.25	$0.00
ROE (TTM)	-5679.0%	-5123.0%
ROA (TTM)	-3050.0%	-3662.0%
ROIC (TTM)	-5425.0%	-5123.0%
Financial Health
Cash	$1M	$39M
Debt	$2M	$0
Net Cash/Debt	$-297K	$39M
Current Ratio (TTM)	0.16x	4.50x
Quick Ratio (TTM)	0.13x	4.37x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.72	0.68
52W Performance	24.2%	-68.7%
YTD Performance	-3.3%	-40.1%
% from 52W High	-28.3%	-74.7%
% from 52W Low	165.8%	4.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.10x
FCF Yield (TTM)	-24.2%	-227.9%
Earnings Yield (TTM)	-62.0%	-175.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5,062.9	-671.6
EV/GP/RG	N/A	N/A
Ticker research	View GRDX research	View MGX research